# Australis Capital

Australis Capital is a Private Equity based in Las Vegas, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Las Vegas, United States
- **Region:** North America
- **Address:** Las Vegas, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** www.ausacap.com
- **LinkedIn:** https://www.linkedin.com/company/australis-group-latam

## Regulatory record

- **Reports private funds:** No

## About

Australis Capital invests in the US cannabis industry through equity, debt, and other securities in public and private companies. Investments include financings for royalties and distribution streams, as well as control stake acquisitions. Australis Capital has made 3 investments, including a January 2019 investment in Folium Biosciences, and 1 portfolio exit, Green Therapeutics, in March 2021.

## Questions

### Who runs investment decisions at Australis Capital?

No named principals or investment committee members are disclosed in public materials.

### Does Australis Capital participate in fund commitments or only direct deals?

Public information shows a focus on direct early-stage and PIPE transactions.

### What investment stages does Australis Capital typically target?

The firm lists early-stage startup and PIPE activity.

## Related profiles

- [Australia Venture Capital](https://altss.com/profile/australia-venture-capital)
- [Austrian Angel Investors Association](https://altss.com/profile/austrian-angel-investors-association)

---

Updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/australis-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology